Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 03/08/20121 min de leitura
Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT); Public Workshop
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research is announcing a 4-day public workshop entitled "Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT)." The purpose of this workshop is to provide a forum to consider issues related to endpoints that can support drug development in the following disease areas: Eosinophilic esophagitis, pediatric and adult inflammatory bowel disease, and parenteral nutrition-associated liver disease.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →